108 related articles for article (PubMed ID: 19914637)
1. Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population.
El Saleeby CM; Li R; Somes GW; Dahmer MK; Quasney MW; DeVincenzo JP
J Pediatr; 2010 Mar; 156(3):409-14. PubMed ID: 19914637
[TBL] [Abstract][Full Text] [Related]
2. SP-A1, SP-A2 and SP-D gene polymorphisms in severe acute respiratory syncytial infection in Chilean infants.
Ampuero S; Luchsinger V; Tapia L; Palomino MA; Larrañaga CE
Infect Genet Evol; 2011 Aug; 11(6):1368-77. PubMed ID: 21601013
[TBL] [Abstract][Full Text] [Related]
3. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection.
Lahti M; Lofgren J; Marttila R; Renko M; Klaavuniemi T; Haataja R; Ramet M; Hallman M
Pediatr Res; 2002 Jun; 51(6):696-9. PubMed ID: 12032263
[TBL] [Abstract][Full Text] [Related]
4. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants.
Löfgren J; Rämet M; Renko M; Marttila R; Hallman M
J Infect Dis; 2002 Feb; 185(3):283-9. PubMed ID: 11807709
[TBL] [Abstract][Full Text] [Related]
5. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
6. Uteroglobulin-related protein 1 and severity of respiratory syncytial virus infection in children admitted to hospital.
Hashimoto K; Katayose M; Sakuma H; Kawasaki Y; Sumikoshi M; Sakata H; Sato M; Ohara S; Abe Y; Watanabe M; Sato T; Ishibashi K; Suzutani T; Munakata M; Hosoya M
J Med Virol; 2011 Jun; 83(6):1086-92. PubMed ID: 21503925
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
[TBL] [Abstract][Full Text] [Related]
8. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.
Janssen R; Bont L; Siezen CL; Hodemaekers HM; Ermers MJ; Doornbos G; van 't Slot R; Wijmenga C; Goeman JJ; Kimpen JL; van Houwelingen HC; Kimman TG; Hoebee B
J Infect Dis; 2007 Sep; 196(6):826-34. PubMed ID: 17703412
[TBL] [Abstract][Full Text] [Related]
10. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course.
Wilkesmann A; Ammann RA; Schildgen O; Eis-Hübinger AM; Müller A; Seidenberg J; Stephan V; Rieger C; Herting E; Wygold T; Hornschuh F; Groothuis JR; Simon A;
Pediatr Infect Dis J; 2007 Jun; 26(6):485-91. PubMed ID: 17529864
[TBL] [Abstract][Full Text] [Related]
11. The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery.
Leidy NK; Margolis MK; Marcin JP; Flynn JA; Frankel LR; Johnson S; Langkamp D; Simoes EA
Pediatrics; 2005 Jun; 115(6):1536-46. PubMed ID: 15930214
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection.
Puthothu B; Krueger M; Forster J; Heinze J; Weckmann M; Heinzmann A
Pediatr Infect Dis J; 2007 Dec; 26(12):1094-8. PubMed ID: 18043444
[TBL] [Abstract][Full Text] [Related]
13. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial.
Kneyber MC; van Woensel JB; Uijtendaal E; Uiterwaal CS; Kimpen JL;
Pediatr Pulmonol; 2008 Feb; 43(2):142-9. PubMed ID: 18085694
[TBL] [Abstract][Full Text] [Related]
14. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.
Thorburn K
Arch Dis Child; 2009 Feb; 94(2):99-103. PubMed ID: 18653625
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis.
Wilson J; Rowlands K; Rockett K; Moore C; Lockhart E; Sharland M; Kwiatkowski D; Hull J
J Infect Dis; 2005 May; 191(10):1705-9. PubMed ID: 15838798
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children.
Wolf DG; Greenberg D; Kalkstein D; Shemer-Avni Y; Givon-Lavi N; Saleh N; Goldberg MD; Dagan R
Pediatr Infect Dis J; 2006 Apr; 25(4):320-4. PubMed ID: 16567983
[TBL] [Abstract][Full Text] [Related]
17. Common human Toll-like receptor 4 polymorphisms--role in susceptibility to respiratory syncytial virus infection and functional immunological relevance.
Paulus SC; Hirschfeld AF; Victor RE; Brunstein J; Thomas E; Turvey SE
Clin Immunol; 2007 Jun; 123(3):252-7. PubMed ID: 17449325
[TBL] [Abstract][Full Text] [Related]
18. The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates.
Howidi M; Rajah J; Abushrar Z; Parsons H
J Trop Pediatr; 2007 Feb; 53(1):22-6. PubMed ID: 17008442
[TBL] [Abstract][Full Text] [Related]
19. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.
Jack DL; Cole J; Naylor SC; Borrow R; Kaczmarski EB; Klein NJ; Read RC
Clin Infect Dis; 2006 Dec; 43(11):1426-33. PubMed ID: 17083016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
